# FDA Inspection 618256 - SmithKline Beecham Ltd. - September 04, 2009

Source: https://www.keypedia.com/records/fda_inspections/smithkline-beecham-ltd/b883d9c2-8a6d-4741-bf24-211f57a5351a
Source feed: FDA_Inspections

> FDA Inspection 618256 for SmithKline Beecham Ltd. on September 04, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 618256
- Company Name: SmithKline Beecham Ltd.
- Inspection Date: 2009-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 899054 - 2014-09-18](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-ltd/5a46e467-7729-4b4d-b963-a3551f7098ec)
- [FDA Inspection 725197 - 2011-04-28](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-ltd/1871b01c-18ff-4614-b1c5-0b0ec791fe4f)

Company: https://www.keypedia.com/companies/smithkline-beecham-ltd/5302ec9d-ed91-4e01-a252-031f108f390d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c